S&P 500   2,994.40 (-0.12%)
DOW   26,963.59 (-0.23%)
QQQ   193.04 (-0.20%)
AAPL   235.80 (+0.63%)
FB   189.62 (-0.03%)
MSFT   138.97 (-0.36%)
AMZN   1,775.28 (-0.84%)
NVDA   193.21 (+0.32%)
MU   44.37 (-2.36%)
BABA   172.59 (-2.07%)
TSLA   259.78 (-1.01%)
F   9.21 (+1.32%)
ACB   3.78 (-0.53%)
PRI   124.26 (+0.24%)
NFLX   282.65 (-3.65%)
BAC   30.21 (+0.47%)
GILD   64.92 (-0.37%)
DIS   132.52 (-0.26%)
S&P 500   2,994.40 (-0.12%)
DOW   26,963.59 (-0.23%)
QQQ   193.04 (-0.20%)
AAPL   235.80 (+0.63%)
FB   189.62 (-0.03%)
MSFT   138.97 (-0.36%)
AMZN   1,775.28 (-0.84%)
NVDA   193.21 (+0.32%)
MU   44.37 (-2.36%)
BABA   172.59 (-2.07%)
TSLA   259.78 (-1.01%)
F   9.21 (+1.32%)
ACB   3.78 (-0.53%)
PRI   124.26 (+0.24%)
NFLX   282.65 (-3.65%)
BAC   30.21 (+0.47%)
GILD   64.92 (-0.37%)
DIS   132.52 (-0.26%)
Log in

BridgeBio Pharma Price Target & Analyst Ratings (NASDAQ:BBIO)

$17.96
-0.90 (-4.77 %)
(As of 10/18/2019 10:26 AM ET)
Today's Range
$17.96
Now: $17.96
$18.41
50-Day Range
$18.27
MA: $24.30
$31.60
52-Week Range
$17.61
Now: $17.96
$32.94
Volume19,915 shs
Average Volume447,328 shs
Market Capitalization$2.10 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

BridgeBio Pharma (NASDAQ:BBIO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for BridgeBio Pharma in the last 12 months. Their average twelve-month price target is $40.13, suggesting that the stock has a possible upside of 123.41%. The high price target for BBIO is $50.00 and the low price target for BBIO is $34.00. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.13$40.13N/AN/A
Price Target Upside: 123.41% upside49.78% upsideN/AN/A

BridgeBio Pharma (NASDAQ:BBIO) Consensus Price Target History

BridgeBio Pharma (NASDAQ:BBIO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/26/2019Raymond JamesInitiated CoverageOutperform ➝ Outperform$36.00High
7/22/2019Svb LeerinkInitiated CoverageOutperform ➝ Outperform$34.00High
7/22/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$38.00High
7/22/2019Leerink SwannInitiated CoverageOutperform$34.00High
7/22/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$38.00High
7/22/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$50.00High
7/22/2019Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$42.00High
7/22/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$49.00High
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel